Tax Rate: 19.38%
Is the tax rate high or low?
The tax rate of 19.38% is 332% above its 5-year average of -8.37%, near the high end of its 5-year range (-269.08%–28.66%).
21.01% below its 12-month average of 24.54%.
PODD Tax Rate
Reported quarterly effective tax rate; periods with non-meaningful pretax income are omitted.
PODD Average Tax Rate Chart
PODD Current vs Average Tax Rate Chart
PODD Tax Rate Metrics
TAX RATE
19.38%
TAX RATE AVG TTM
24.54%
TAX RATE AVG 3Y
13.33%
TAX RATE AVG 5Y
13.65%
TAX RATE AVG 10Y
N/A
TAX RATE AVG 15Y
N/A
TAX RATE AVG 20Y
N/A
CURRENT VS TTM AVG
-21.01%
CURRENT VS 3Y AVG
+45.44%
CURRENT VS 5Y AVG
+41.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Tax Rate Formula & Definition
Tax rate measures income tax expense as a percentage of income before tax. It helps compare tax efficiency and identify unusual tax effects.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Tax Rate FAQ
- What is the tax rate for Insulet Corp. (PODD)?
- The tax rate for PODD stock is 19.38%.
- Is Insulet Corp.'s tax rate high or low?
- The tax rate of 19.38% is 332% above its 5-year average of -8.37%, near the high end of its 5-year range (-269.08%–28.66%).
- What is the TTM average tax rate for Insulet Corp. (PODD)?
- The TTM average tax rate for PODD stock is 24.54%.
- What is the 3Y average tax rate for Insulet Corp. (PODD)?
- The 3Y average tax rate for PODD stock is 13.33%.
- What is the 5Y average tax rate for Insulet Corp. (PODD)?
- The 5Y average tax rate for PODD stock is 13.65%.
PODD Tax Rate History
| DATE | TAX RATE |
|---|---|
| 2026-03-31 | 19.38% |
| 2025-12-31 | 27.46% |
| 2025-09-30 | 28.66% |
| 2025-06-30 | 20.77% |
| 2025-03-31 | 26.40% |
| 2024-12-31 | 9.52% |
| 2024-09-30 | 6.51% |
| 2024-06-30 | -269.08% |
| 2024-03-31 | 6.19% |
| 2023-12-31 | 4.17% |
| 2023-09-30 | 3.35% |
| 2023-06-30 | 4.21% |
| 2023-03-31 | 3.25% |
| 2022-12-31 | 23.77% |
| 2022-03-31 | 5.12% |
| 2021-12-31 | 12.57% |
| 2021-09-30 | 17.11% |
| 2021-03-31 | -100.00% |
| 2020-09-30 | 13.43% |
| 2020-06-30 | 17.24% |
| 2019-12-31 | 26.75% |
| 2019-09-30 | 27.27% |
| 2019-06-30 | 26.32% |
| 2019-03-31 | 6.38% |
| 2018-12-31 | 9.14% |
| 2018-09-30 | 10.47% |
Related Metrics
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy